FERNDALE, Mich.--(BUSINESS WIRE)--A line of transparent post-operative dressings designed to enhance patient care will be jointly introduced by Eloquest Healthcare®, Inc. and Vancive Medical Technologies™, an Avery Dennison (NYSE:AVY) business at AORN in Boston, MA. The device just received 510(k) clearance from the FDA.
The new dressings, called ReliaTect™, incorporate BeneHold™ CHG, an innovative adhesive technology from Vancive Medical Technologies, that comfortably secures the dressing to the skin, absorbs fluids and protects the site from external contaminants. The CHG contained within the adhesive preserves the dressings from microbial growth, making them ideally suited for post-operative sites. Eloquest Healthcare is the exclusive distributor of the dressings in the United States and Canada.
“The unique characteristics of the ReliaTect post-operative dressings make them a great complement to our growing portfolio and increases the value we are able to provide to our customers,” said Tim O’Halla, President and CEO for Eloquest Healthcare. “The BeneHold CHG adhesive technology delivers the combination of fluid management and sustained transparency with antimicrobial effect of chlorhexidine gluconate, offering clinicians a simple and innovative solution for post-op site management.”
The ReliaTect dressings will be available in two sizes (small and large) and designed to be ideal for various post-operative sites.
“BeneHold CHG adhesive technology adds value to post-operative dressings,” said Kirsten Newquist, general manager for Vancive Medical Technologies. “The collaboration with Eloquest Healthcare brings together complementary resources, experience and expertise from each company. We look forward to working with Eloquest Healthcare to bring ReliaTect to market.”
Eloquest Healthcare and Vancive Medical Technologies will showcase the new Eloquest Healthcare ReliaTect dressings in booth #3019 at the AORN Global Surgical Conference & Expo, April 2—4 in Boston, MA. To learn more about the Eloquest Healthcare ReliaTect post-operative dressings with CHG, visit http://www2.eloquesthealthcare.com/ReliaTectLaunch.
About Eloquest Healthcare
Eloquest Healthcare, Inc. is a wholly owned subsidiary of Ferndale Pharma Group, Inc. that is focused specifically on serving hospitals, their healthcare practitioners, and patients. Eloquest Healthcare helps deliver safer, more compassionate care by providing intuitive, cost-effective solutions that complement treatment protocols. More information can be found at www.eloquesthealthcare.com.
About Vancive Medical Technologies
Vancive Medical Technologies is a medical technology company with more than three decades of expertise in adhesive chemistries and material technologies for medical applications using pressure sensitive adhesives. The company's applications and technologies are an integral part of products that are in daily use in medical facilities throughout the world. Through long-term relationships with original equipment manufacturers, industry-specific converters and leading universities, Vancive Medical Technologies continually finds new ways to develop products that can improve patient care. Vancive Medical Technologies is an Avery Dennison business headquartered in Chicago, Illinois. To learn more about Vancive Medical Technologies, visit www.vancive.averydennison.com.
About Avery Dennison
Avery Dennison (NYSE:AVY) is a global leader in pressure-sensitive and functional materials and labeling solutions for the retail apparel market. The company’s applications and technologies are an integral part of products used in every major industry. With operations in more than 50 countries and more than 25,000 employees worldwide, Avery Dennison serves customers in the consumer packaging, graphical display, logistics, apparel, industrial and healthcare industries. Headquartered in Glendale, California, the company reported sales of $6.1 billion in 2016. Learn more at www.averydennison.com.
